losartan has been researched along with Glaucoma, Suspect in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Korneva, A | 1 |
| Schaub, J | 1 |
| Jefferys, J | 1 |
| Kimball, E | 1 |
| Pease, ME | 1 |
| Nawathe, M | 1 |
| Johnson, TV | 1 |
| Pitha, I | 1 |
| Quigley, H | 1 |
1 other study available for losartan and Glaucoma, Suspect
| Article | Year |
|---|---|
A method to quantify regional axonal transport blockade at the optic nerve head after short term intraocular pressure elevation in mice.
Topics: Amyloid beta-Protein Precursor; Animals; Antihypertensive Agents; Axonal Transport; Axons; Disease M | 2020 |